Term
Cyclophosphamide (drug type) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Non-classic alkylating agent |
|
|
Term
|
Definition
|
|
Term
5-Flourouracil (drug type) |
|
Definition
Thymidylate synthetase inhibitor (dny synthesis inhibitor) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Mercaptopurine (drug type) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Ribonucleotide reductase inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Cetuximab, Panitumumab, Gefitinib, Erlotinib (drug type) |
|
Definition
EGFR-tyrosine kinase inhibitor |
|
|
Term
Trastuzumab, Laptinib (drug type, cancer) |
|
Definition
EGFR-tyrosine kinase inhibitor, For Breast Cancer |
|
|
Term
Imatinib, Nilotinib, Dasatinib (drug type, cancer) |
|
Definition
BCR-ABL tyrosinde kinase inhibitor, for CML |
|
|
Term
Vemurafenib (drug type, cancer) |
|
Definition
RAS/Map kinase pathway inhibitor, for melanoma |
|
|
Term
Sorafenib, Sunitinib (drug type, cancer) |
|
Definition
RAS/Map kinase pathway inhibitor, for renal cell cancer |
|
|
Term
Temsirolimus, Everolimus (drug type, cancer) |
|
Definition
mTOR inhibitor, for renal cell cancer |
|
|
Term
|
Definition
|
|
Term
Bevacizumab, thalidomide, lenalidomide (drug type) |
|
Definition
|
|
Term
|
Definition
Histone deacetylase inhibitor |
|
|
Term
Tamoxifen, Fluvestrant, Raloxifene, Toremifene (drug type) |
|
Definition
Selective estrogen receptor modulators |
|
|
Term
Anastrozole, Letrozole, Exemestane (drug type, cancer) |
|
Definition
Aromatase inhibitors, for post-menopausal women |
|
|
Term
Bicalutamide, Flutamide (drug type, cancer) |
|
Definition
Androgen receptor antagonist, for Prostate cancer |
|
|
Term
Leuprolide, Goserelin, Triptorelin (drug type) |
|
Definition
Luteinizing Hormone Release hormone agonists |
|
|